Yang Y, Hao C, Jiao T, Yang Z, Li H, Zhang Y, Zhang W, Doherty M, Sun C, Yang T, Li J, Wu J, Zhang M, Wang Y, Xie D, Wang T, Wang N, Huang X, Li C, Gonzalez FJ, Wei J, Xie C, Zeng C, Lei G
FIGURE 1 2 Phytochemical-based nanosystems for gene and tumor microenvironment targeting 2.1 Formulation challenges and delivery strategies While plant-derived drugs such as vincristine, paclitaxel, and docetaxel are established in oncology, they represent only a small fraction of phytochemicals with demonstrated preclinical anticancer activity that have yet to translate into routine clinical use (Figure 1) (Mazumder et al., 2022
UPGRADE Not enough biomarkers? Check out theUltimate Longevity Blood Test, for a comprehensive body check up
One potential concern is the dose